View Author
patient study therapy response baseline t-cell hepatitis group treatment virus level regimen analysis haart hiv-infected patients hepatitis c country netherland rosiglitazone infection hcv-speci migration mortality load decrease admission sequence switch period number failure antiretroviral decrease haart era assay change effect antiretroviral therapy virological migration events subtype signi ribavirin atv switch group icu admission event cart group postprandial virologic resistance phase hepatitis c virus hcv mono-infected patients disease fi rst phase hiv-infected population lipid hbv dna liver outcome difference hcv /hiv patients signi ficantly metformin result department pre-haart era virological failure inhibitor lipodystrophy mono-infected follow-up postprandial lipemia table europe trial pre-haart 48 weeks ef ficacy diabetes
8 Most Recent Publications
|
Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit
(Article)
Lelyveld, S.F.L. van Wind, C.M. Mudrikova, T. Leeuwen, H.J. van Lange, D.W. de Hoepelman, I.M. |
2011-02-18
|
|
Differential effects of rosiglitazone and metformin on postprandial lipemia in patients with HIV-lipodystrophy
(Article)
Wijk, J.P.H. van Hoepelman, I.M. Koning, E.J.P. de Dallinga-Thie, G.M. Rabelink, T.J. Cabezas, M.C. |
2011-01-01
|
|
Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis b virus
(Article)
Vriessluijs, T.E.M.S. de Reijnders, J.G.P. Man, R.A. de Janssen, H.L.A. Ende, M.E. van der Hansen, B.E. Zaaijer, H.L. Prins, J.M. Pas, S.D. Schutten, M. Hoepelman, I.M. Richter, C. Mulder, J.W. |
2010-12-01
|
|
T-cell responses at baseline and during therapy with peginterferon-α and ribavirin are not associated with outcome in chronic hepatitis C infected patients
(Article)
Arends, J.E. Claassen, M.A.A. Berg, C.H.S.B. van den Nanlohy, N.M. Erpecum, K.J. van Baak, B.C. Hoepelman, I.M. Boonstra, P.A. Baarle, D. van |
2010-09-01
|
|
Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results
(Article)
Sprenger, H.G. Langebeek, N. Kate, R.W. ten Groeneveld, P.H.P. Werf, T.S. van der Gisolf, E.H. Richter, C. Mulder, P.G.H. Ten Napel, C.H.H. Vriesendorp, R. Hoepelman, I.M. Legrand, J.C. Koopmans, P.P. Kasteren, M.E.E. van Bravenboer, B. |
2010-06-01
|
|
Plasma HCV-RNA decline in the first 48 h identifies hepatitis C virus mono-infected but not HCVHIV-coinfected patients with an undetectable HCV viral load at week 4 of peginterferon-alfa-2aribavirin therapy
(Article)
Arends, J.E. Stuart, J.C. Baak, L.C. Ende, M.E. van der Erpecum, K.J. van Simons, C.P.M. Boland , G.J. Baarle, D. van Hoepelman, I.M. |
2009-12-01
|
|
Tracing the HIV-1 subtype B mobility in Europe: A phylogeographic approach
(Article)
Paraskevis, D. Pybus, O. Boeri, E. Camacho, R.J. Chaix, M.-L. Coughlan, S. Costagliola, D. Luca, A. de Mendoza, C. de Derdelinckx, I. Grossman, Z. Hamouda, O. Magiorkinis, G. Hoepelman, I.M. Horban, A. Korn, K. Kücherer, C. Leitner, T. Loveday, C. MacRae, E. Maljovic-Berry, I. Meyer, L. Nielsen, C. Hatzakis, A. Op de Coul, E.L.M. Ormaasen, V. Perrin, L. Puchhammer-Stöckl, E. Ruiz, L. Wensing, A.M.J. Vijver, D.A.M.C. van de Albert, J. Angarano, G. Åsjö, B. Balotta, C. |
2009-05-20
|
|
Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir
(Article)
Vonderen, M.G.A. van Gras, L. Wit, F.W. Brinkman, K. Ende, M.E. van der Hoepelman, I.M. Wolf, F. de Reiss, P. |
2009-01-01
|
